Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Labopharm (DDSS)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
OPERATING METRICS
REVENUE SOURCES
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for DDSS as compared to
Top Competitors
Drug Related Products.
Drug Related Products
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS (
See all
)
Revenue
►
15.5M
LOW
R&D Expense
►
23.6M
AVG
Revenue
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
15.5M
LOW
EBITDA
►
-13.0M
LOW
Net Income
►
-17.0M
LOW
Revenue Growth
►
-20.4%
LOW
Operating Margin
►
-96.3%
VERY LOW
Net Margin
►
-109.4%
VERY LOW
Revenue, Gross Profit, and Gross Margin
Operating Income
Interest vs Continuing Income
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
-6.78
Current Ratio
►
1.45
LOW
Quick Ratio
►
1.34
AVG
Interest Coverage Ratio
►
-5.53
AVG
Book Value Per Share
►
-0.133
Cash Per Share
►
0.236
Loading...
STOCK SUMMARY
Open
Day Range
-
52 Week Range
-
Volume
Avg Volume (3 mo)
Shares Outstanding
Market Cap
VALUATION
Price to Earnings (P/E)
►
-4.97
Price to Book (P/B)
►
-11.0
Price to Sales (P/S)
►
5.44
HIGH
Return on Assets (ROA)
►
-26.2%
AVG
Return on Equity (ROE)
►
-200.6%
LOW
EV/EBITDA
►
-9.07
ANALYST RECOMMENDATIONS
OWNERSHIP
Held by institutions
4.8%